Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 34Colonic Neoplasms 18Rectal Neoplasms 14Pancreatic Neoplasms 8Esophageal Neoplasms 7Adenomatous Polyposis Coli 7Liver Neoplasms 5Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Turcot syndrome 2Thymoma 2Neoplasms 2Lung Neoplasms 2Locally Advanced Rectal Cancer 2Hand-Foot Syndrome 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Thrombocytosis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polyps 1Pancreatic Cancer Metastatic 1Pain, Postoperative 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 76Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Celecoxib × Gastrointestinal × Clear all
NCT00256321 2019-02-08

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

University of California, Irvine

Phase 2 Terminated
4 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡